New era of artificial pneumothorax in the management of multidrug resistant (MDR) pulmonary tuberculosis

V. Y. Mishin, I. A. Vassilieva (Moscow, Russia)

Source: Annual Congress 2003 - The various appearance of resistance
Session: The various appearance of resistance
Session type: Oral Presentation
Number: 3493
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. Y. Mishin, I. A. Vassilieva (Moscow, Russia). New era of artificial pneumothorax in the management of multidrug resistant (MDR) pulmonary tuberculosis. Eur Respir J 2003; 22: Suppl. 45, 3493

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Artificial pneumothorax in the treatment of multi drug resistant tuberculosis (MDR TB)
Source: Eur Respir J 2006; 28: Suppl. 50, 586s
Year: 2006

Surgical treatment of multidrug resistant pulmonary tuberculosis (MDR-TB)
Source: Annual Congress 2009 - Treatment of tuberculosis at times of emerging drug resistance
Year: 2009


Surgical treatment of destructive pulmonary tuberculosis (TB) with multi-drug resistance (MDR)
Source: Eur Respir J 2004; 24: Suppl. 48, 723s
Year: 2004

Treatment results of multidrug resistant pulmonary tuberculosis (MDR-TB)
Source: Eur Respir J 2005; 26: Suppl. 49, 199s
Year: 2005

Treatment of multidrug resistant pulmonary tuberculosis (MDR-TB) with different pattern of resistance
Source: Eur Respir J 2004; 24: Suppl. 48, 723s
Year: 2004

Recurrence after successful treatment of pulmonary tuberculosis (TB) with multidrug-resistance (MDR)
Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis
Year: 2008


Treatment possibilities of multi-drug resistant (MDR) tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 525s
Year: 2003

New method of treatment of MDR destructive pulmonary tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 527s
Year: 2003

Multidrug resistant tuberculosis (MDR – TB) treatment outcomes in Iran
Source: Eur Respir J 2004; 24: Suppl. 48, 657s
Year: 2004

Our experience in multi drug resistant tuberculosis (MDR TB) treatment
Source: Eur Respir J 2005; 26: Suppl. 49, 652s
Year: 2005

Characteristics of the cases with primary multidrug resistance pulmonary tuberculosis
Source: Eur Respir J 2005; 26: Suppl. 49, 652s
Year: 2005

Outcome of multidrug resistant pulmonary tuberculosis
Source: Annual Congress 2010 - Tuberculosis drug resistance
Year: 2010


The surgery of multidrug resistant tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 556s
Year: 2003

Surgical treatment of multidrug-resistant tuberculosis (MDR TB)
Source: Eur Respir J 2003; 22: Suppl. 45, 523s
Year: 2003

The clinical and radiological comparison of new, recurrent and multidrug resistant cases of pulmonary tuberculosis
Source: Eur Respir J 2002; 20: Suppl. 38, 169s
Year: 2002

Comparative analysis between multidrug resistant tuberculosis (MDR-TB) and extensively drug resistant tuberculosis (XDR-TB) in HIV(+) patients
Source: Annual Congress 2009 - Tuberculosis and HIV co-infection
Year: 2009


Short course of chemotherapy of multidrug resistant tuberculosis (MDR TB)
Source: Eur Respir J 2004; 24: Suppl. 48, 722s
Year: 2004

Management of MDR tuberculosis
Source: Short video discussion 2021
Year: 2021

Efficacy and safety of linezolid for the treatment of multidrug resistant tuberculosis (MDR-TB) and disease by non tuberculous mycobacteria (NTM)
Source: Annual Congress 2011 - Treatment of tuberculosis and adverse drug reactions
Year: 2011

The efficiency of surgical treatment for multidrug-resistant pulmonary and pleural tuberculosis
Source: International Congress 2016 – Surgical strategy for complex diseases
Year: 2016